GOLM1 and hepatocellular carcinoma: The authors believed that GP73 could not accurately distinguish HCC patients from non-HCC patients with cirrhosis [14].Because of this controversy, we collected relevant literature to conduct a meta-analysis to evaluate the diagnostic value of GP73 for HCC with varying groups of control.